Dr Reddy's launches generic SEROQUEL tablets in US
Dr Reddy's Laboratories has launched Quetiapine fumarate tablets of strengths, 25mg, 50mg, 100mg, 200mg, 300mg and 400mg.
The launch of bioequivalent generic version of SEROQUEL tablets is followed by the FDA approval of Dr Reddy's ANDA.
Quetiapine fumarate tablets in 25mg and 50mg are available in 100 and 500 count bottle sizes, 100mg, 200mg and 400mg are available in 100 count bottle sizes and 300mg is available in 60 count bottle sizes.
The SEROQUEL brand had US sales of approximately $4.6bn for the most recent twelve months ending December 2011, according to IMS Health.
Latest News
Related News
Related Sectors
Drug Research> Drug Discovery & Development
Related Dates
2012> March
Related Industries
Pharmaceuticals and Healthcare> Services> Technology> Drug Discovery
Drug Research> Drug Discovery & Development
Related Dates
2012> March
Related Industries
Pharmaceuticals and Healthcare> Services> Technology> Drug Discovery
Related Insight
Suppliers Directory
GoIndustry DoveBid - Industrial Asset Management, Auction and Valuation Services
GoIndustry DoveBid plc is the global market leader in the provision of asset management, auction and valuation services relating to industrial equipment.
Drug Research > Drug Discovery & Development > Suppliers
InnoCore Technologies BV – Injectable and Implantable Drug Delivery Products and Drug-Eluting Medical Devices
InnoCore is a drug delivery company providing controlled release systems for the pharmaceutical and medical device industry.
Drug Research > Drug Discovery & Development > Suppliers
Bioceros - Pre-Clinical Development of Monoclonal Antibodies and Generation of GMP-Ready Proteins
Bioceros is one of Europe's premier providers of services in pre-clinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines.
Drug Research > Drug Discovery & Development > Suppliers
VERTIS Biotechnologie - Next Generation RNA Sequencing & Gene Regulation Analyses
VERTIS is a privately owned research organisation with a focus on Next Generation Sequencing (NGS) especially on transcriptome sequencing (RNA-seq). It was founded in 2000 as a spin-off from the Technische Universität München (TUM) - Weihenstephan. The company offers a complete product line, ranging from project consulting, nucleic acid isolation, sample preparation and DNA sequencing to bioinformatic sequence analysis and data mining.
Drug Research > Drug Discovery & Development > Suppliers
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Discovery & Development Intelligence
TOyOPEARl® AF-rProtein A-650F
Published by Tosoh Bioscience
Drug Research > Drug Discovery & Development > White Papers
TM-II Tool Management Systems
Published by Natoli Engineering Company
Drug Research > Drug Discovery & Development > White Papers
CYNCRON - an Overview
Published by CYNCRON
Drug Research > Drug Discovery & Development > White Papers
Nonclinical Development of Biopharmaceuticals
Published by MPI Research
Drug Research > Drug Discovery & Development > White Papers
Buy the latest industry research online today!
African Pharmaceutical Directory 2013
API research into pharmaceutical companies and corporations Buy online from $200
API research into pharmaceutical companies and corporations Buy online from $200

Comments may be moderated for spam, obscenities or defamation.